S27 Effect of high ICS dose fixed combination extrafine beclomethasone dipropionate, formoterol fumarate, and glycopyrronium (BDP/FF/G) pMDI on asthma control in patients with persistent airflow limitation (PAL): a post-hoc analysis of the TRIGGER study

Fixed Combination ◽

Airflow Limitation ◽

Post Hoc Analysis ◽

Post Hoc ◽

Effect of High ICS Dose Fixed Combination Extra Fine Beclomethasone Dipropionate, Formoterol Fumarate, and Glycopyrronium Bromide (BDP/FF/GB) on Lung Function in Asthmatics with Persistent Airflow Limitation (PAL): A Post-Hoc Analysis of the TRIGGER Study

10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a3005 ◽

2020 ◽

Author(s):

D. Singh ◽

G.W. Cononica ◽

J.C. Virchow ◽

M. Kots ◽

F. Zuccaro ◽

...

Keyword(s):

Lung Function ◽

Fixed Combination ◽

Airflow Limitation ◽

Glycopyrronium Bromide ◽

Post Hoc Analysis ◽

Post Hoc ◽

Effect of Medium ICS Dose Fixed Combination Extra Fine Beclomethasone Dipropionate, Formoterol Fumarate, and Glycopyrronium Bromide (BDP/FF/GB) pMDI on Lung Function in Asthmatics with Persistent Airflow Limitation (PAL): A Post-Hoc Analysis of the Trimaran Study

10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a3009 ◽

2020 ◽

Author(s):

J.C. Virchow ◽

G.W. Canonica ◽

D. Singh ◽

M. Kots ◽

S. Corre ◽

...

Keyword(s):

Lung Function ◽

Fixed Combination ◽

Airflow Limitation ◽

Glycopyrronium Bromide ◽

Post Hoc Analysis ◽

Post Hoc ◽

Normalization of Airflow Obstruction with Extra Fine Beclomethasone Dipropionate, Formoterol Fumarate, and Glycopyrronium Bromide (BDP/FF/GB) pMDI: A Post-Hoc Analysis of the TRIMARAN and TRIGGER Studies

10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a1437 ◽

2021 ◽

Author(s):

J.C. Virchow ◽

D. Singh ◽

W.G. Canonica ◽

A. Vele ◽

G. Georges ◽

...

Keyword(s):

Airflow Obstruction ◽

Glycopyrronium Bromide ◽

Post Hoc Analysis ◽

Post Hoc ◽

The efficacy of extrafine beclomethasone dipropionate–formoterol fumarate in COPD patients who are not "frequent exacerbators": a post hoc analysis of the FORWARD study

International Journal of Chronic Obstructive Pulmonary Disease ◽

10.2147/copd.s141416 ◽

2017 ◽

Vol Volume 12 ◽

pp. 3263-3271 ◽

Cited By ~ 2

Author(s):

Dave Singh ◽

Stefano Vezzoli ◽

Stefano Petruzzelli ◽

Alberto Papi

Keyword(s):

Post Hoc Analysis ◽

Copd Patients ◽

Post Hoc ◽

Effects of Netarsudil and Latanoprost Alone and in Fixed Combination on Corneal Endothelium and Corneal Thickness: Post-Hoc Analysis of MERCURY-2

Advances in Therapy ◽

10.1007/s12325-020-01227-y ◽

2020 ◽

Vol 37 (3) ◽

pp. 1114-1123 ◽

Cited By ~ 2

Author(s):

C. Ellis Wisely ◽

Huan Sheng ◽

Theresa Heah ◽

Terry Kim

Keyword(s):

Corneal Endothelium ◽

Fixed Combination ◽

Corneal Thickness ◽

Post Hoc Analysis ◽

Post Hoc

Predictors of loss of asthma control in the Phase 2a INCONTRO trial: A post-hoc analysis

10.1183/13993003.congress-2020.2278 ◽

2020 ◽

Author(s):

Robert Palmér ◽

Joachim Almquist ◽

Mahdi Hashemi ◽

Ziad Taib ◽

Sofia Necander ◽

...

Keyword(s):

Asthma Control ◽

Post Hoc Analysis ◽

Post Hoc

Asthma Control and Study Withdrawal in Patients With Versus Without Fixed Airflow Obstruction (2 Criteria): Post Hoc Analysis of a Budesonide/Formoterol Pressurized Metered-Dose Inhaler Study in Patients With Moderate to Severe Asthma

CHEST Journal ◽

10.1378/chest.1371955 ◽

2012 ◽

Vol 142 (4) ◽

pp. 686A

Author(s):

Donald Tashkin ◽

Bradley Chipps ◽

Tom Uryniak ◽

Frank Trudo ◽

James Zangrilli

Keyword(s):

Asthma Control ◽

Severe Asthma ◽

Airflow Obstruction ◽

Dose Inhaler ◽

Metered Dose Inhaler ◽

Post Hoc Analysis ◽

Metered Dose ◽

Pressurized Metered Dose Inhaler ◽

Post Hoc ◽

Fixed Airflow Obstruction

Benefits of Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler in Patients with Chronic Obstructive Pulmonary Disease by Baseline CAT Score: Post-Hoc Analysis of the ETHOS Study

10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a2246 ◽

2021 ◽

Author(s):

J. Hurst ◽

F.J. Martinez ◽

D. Singh ◽

P. Darken ◽

M. Patel ◽

...

Keyword(s):

Chronic Obstructive Pulmonary Disease ◽

Pulmonary Disease ◽

Dose Inhaler ◽

Chronic Obstructive ◽

Metered Dose Inhaler ◽

Obstructive Pulmonary Disease ◽

Post Hoc Analysis ◽

Metered Dose ◽

Post Hoc ◽

Seasonal Variation in COPD Exacerbations: a Post-Hoc Analysis from the KRONOS Phase III Study of Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler (BGF MDI)

10.1055/s-0039-3403160 ◽

2020 ◽

Author(s):

KF Rabe ◽

LM Fabbri ◽

FJ Martinez ◽

GT Ferguson ◽

E Bourne ◽

...

Keyword(s):

Seasonal Variation ◽

Phase Iii ◽

Dose Inhaler ◽

Metered Dose Inhaler ◽

Post Hoc Analysis ◽

Copd Exacerbations ◽

Metered Dose ◽

Phase Iii Study ◽

Post Hoc ◽

Triple therapy in COPD: new evidence with the extrafine fixed combination of beclomethasone dipropionate, formoterol fumarate, and glycopyrronium bromide

International Journal of Chronic Obstructive Pulmonary Disease ◽

10.2147/copd.s146822 ◽

2017 ◽

Vol Volume 12 ◽

pp. 2917-2928 ◽

Cited By ~ 16

Author(s):

Dave Singh ◽

Massimo Corradi ◽

Monica Spinola ◽

Alberto Papi ◽

Omar Usmani ◽

...

Keyword(s):

Triple Therapy ◽

Fixed Combination ◽

Glycopyrronium Bromide ◽

New Evidence ◽